首页> 外文期刊>Journal of the American Chemical Society >Development of α-Helical Calpain Probes by Mimicking a Natural Protein-Protein Interaction
【24h】

Development of α-Helical Calpain Probes by Mimicking a Natural Protein-Protein Interaction

机译:通过模仿天然蛋白质-蛋白质相互作用的α-螺旋钙蛋白酶探针的发展。

获取原文
获取原文并翻译 | 示例
           

摘要

We have designed a highly specific inhibitor of calpain by mimicking a natural protein-protein interaction between calpain and its endogenous inhibitor calpastatin. To enable this goal we established a new method of stabilizing an a-helix in a small peptide by screening 24 commercially available cross-linkers for successful cysteine alkylation in a model peptide sequence. The effects of cross-linking on the a-helicity of selected peptides were examined by CD and NMR spectroscopy, and revealed structurally rigid cross-linkers to be the best at stabilizing α-helices. We applied this strategy to the design of inhibitors of calpain that are based on calpastatin, an intrinsically unstable polypeptide that becomes structured upon binding to the enzyme. A two-turn a-helix that binds proximal to the active site cleft was stabilized, resulting in a potent and selective inhibitor for calpain. We further expanded the utility of this inhibitor by developing irreversible calpain family activity-based probes (ABPs), which retained the specificity of the stabilized helical inhibitor. We believe the inhibitor and ABPs will be useful for future investigation of calpains, while the cross-linking technique will enable exploration of other protein-protein interactions.
机译:我们通过模仿钙蛋白酶及其内源性抑制剂钙蛋白酶抑制素之间的天然蛋白质-蛋白质相互作用,设计了一种高度特异性的钙蛋白酶抑制剂。为实现此目标,我们通过筛选24种可商业获得的交联剂,以在模型肽序列中成功进行半胱氨酸烷基化,从而建立了一种稳定小肽中a-螺旋的新方法。通过CD和NMR光谱检查了交联对所选肽的a-螺旋的影响,发现结构刚性的交联剂最稳定α-螺旋。我们将这种策略应用于基于calpastatin的calpain抑制剂的设计,calcastatin是一种固有的不稳定多肽,与多肽结合后结构化。与活动部位裂口近端结合的两匝α-螺旋被稳定化,产生了钙蛋白酶的有效和选择性抑制剂。我们通过开发基于不可逆钙蛋白酶家族活性的探针(ABP)进一步扩大了该抑制剂的用途,该探针保留了稳定的螺旋抑制剂的特异性。我们相信抑制剂和ABPs将对钙蛋白酶的进一步研究有用,而交联技术将使其他蛋白质-蛋白质相互作用的探索成为可能。

著录项

  • 来源
    《Journal of the American Chemical Society》 |2012年第42期|17704-17713|共10页
  • 作者单位

    Department of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, California 94143, United States,Department of Biochemistry and Protein Function Discovery, Queen's University, Kingston, Ontario K7L 3N6, Canada;

    Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States,Department of Biochemistry and Protein Function Discovery, Queen's University, Kingston, Ontario K7L 3N6, Canada;

    Department of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, California 94143, United States;

    Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States;

    Department of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, California 94143, United States;

    Department of Biochemistry and Protein Function Discovery, Queen's University, Kingston, Ontario K7L 3N6, Canada;

    Department of Biochemistry and Protein Function Discovery, Queen's University, Kingston, Ontario K7L 3N6, Canada;

    Department of Pharmaceutical Chemistry, University of California - San Francisco, San Francisco, California 94143, United States;

    Department of Pharmacology, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States;

  • 收录信息 美国《科学引文索引》(SCI);美国《工程索引》(EI);美国《生物学医学文摘》(MEDLINE);美国《化学文摘》(CA);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号